zalcitabine has been researched along with Pain in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Galeotti, N; Herdegen, T; Manassero, G; Sanna, MD; Vercelli, A | 1 |
| Galeotti, N; Ghelardini, C; Quattrone, A; Sanna, MD | 1 |
| Galeotti, N; Ghelardini, C; Mello, T; Quattrone, A; Sanna, MD | 1 |
| Galeotti, N; Ghelardini, C; Peroni, D; Quattrone, A; Sanna, MD | 1 |
| Chen, X; Levine, JD | 1 |
| Blackbeard, J; Hasnie, F; Lambert, DM; Pheby, T; Rice, AS; Segerdahl, AR; Vandevoorde, S; Wallace, VC | 1 |
| García-Díez, A; Jones-Caballero, M; Peñas, PF | 1 |
| Broder, S; Dalakas, M; Dubinsky, RM; Yarchoan, R | 1 |
8 other study(ies) available for zalcitabine and Pain
| Article | Year |
|---|---|
The isoform-specific functions of the c-Jun N-terminal kinase (JNK) in a mouse model of antiretroviral-induced painful peripheral neuropathy.
Topics: Animals; Anti-Retroviral Agents; Disease Models, Animal; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Mice, Knockout; Pain; Peripheral Nervous System Diseases; Zalcitabine | 2020 |
PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy.
Topics: Animals; Anti-HIV Agents; Brain; Disease Models, Animal; ELAV Proteins; ELAV-Like Protein 4; GAP-43 Protein; Hyperalgesia; Male; Mice; Pain; Peripheral Nervous System Diseases; Protein Kinase C; Reverse Transcriptase Inhibitors; Zalcitabine | 2014 |
The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
Topics: Animals; Anti-Retroviral Agents; Cells, Cultured; Disease Models, Animal; ELAV Proteins; GAP-43 Protein; Gene Expression Regulation; Hyperalgesia; Male; Mice; Neurons; Oligodeoxyribonucleotides, Antisense; Pain; Peripheral Nervous System Diseases; Phosphopyruvate Hydratase; Protein Kinase C; Spinal Cord; Time Factors; Zalcitabine | 2014 |
Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.
Topics: Analgesics, Non-Narcotic; Animals; Anti-HIV Agents; Apomorphine; Calcium Channel Blockers; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Dopamine Uptake Inhibitors; ELAV Proteins; ELAV-Like Protein 4; Exploratory Behavior; Gene Expression Regulation; Hyperalgesia; Male; Mice; Motor Activity; Neuroblastoma; Pain; Pain Threshold; Peripheral Nervous System Diseases; Ryanodine Receptor Calcium Release Channel; Spinal Cord; Zalcitabine | 2015 |
Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat.
Topics: Acquired Immunodeficiency Syndrome; Alcoholic Neuropathy; Animals; Comorbidity; Disease Models, Animal; Ethanol; Mechanics; Mechanotransduction, Cellular; Nerve Fibers, Unmyelinated; Pain; Peripheral Nervous System Diseases; Rats; Zalcitabine | 2007 |
The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.
Topics: Amides; Amines; Animals; Behavior, Animal; Camphanes; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Gabapentin; gamma-Aminobutyric Acid; Hindlimb; Indoles; Injections, Intraperitoneal; Male; Pain; Pain Measurement; Pain Threshold; Palmitic Acids; Physical Stimulation; Piperidines; PPAR alpha; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Sciatic Neuropathy; Temperature; Zalcitabine | 2007 |
Association between zalcitabine therapy for human immunodeficiency virus and granuloma annulare?
Topics: Adult; Female; Granuloma Annulare; HIV Infections; Humans; Pain; Remission, Spontaneous; Zalcitabine; Zidovudine | 2001 |
Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Axons; Dose-Response Relationship, Drug; Electromyography; Humans; Pain; Peripheral Nervous System Diseases; Zalcitabine | 1989 |